Urges and requests certain state universities and research entities to pursue opportunities for research on the safety and clinical efficacy of therapeutic marijuana.
Marijuana; clinical research trials
A CONCURRENT RESOLUTION calling for the expediting of research regarding the safety and efficacy of the use of marijuana for medical purposes.
Authorizes a data system for collection of information on health effects and outcomes associated with medical marijuana (RE INCREASE SG EX See Note)
Urges and requests state entities that have a role in the implementation of Act No. 96 of the 2016 Regular Session relative to patient access to therapeutic marijuana to prioritize fully implementing the law as soon as possible
Authorizes certain universities to conduct research and testing of state-regulated industrial hemp, CBD, and medical marijuana products (OR INCREASE GF EX See Note)
Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (BDR R-801)
Reforms the state systems for regulating the production of marijuana for therapeutic use and for the dispensing of such product (EN INCREASE SG EX See Note)
Urging the Medical Marijuana Advisory Board to encourage and facilitate State System of Higher Education universities to secure United States Drug Enforcement Administration registrations to authorize the possession of cannabis for clinical registrants to engage in hands-on work regarding cultivating, testing, processing and researching cannabis plants.
Urges and requests the Dept. of Health and Hospitals and LSU Board of Supervisors to conduct a study assessing the current and future delivery of health care and medical education in La. and to make recommendations